WITHDRAWN: Expression of concern: "Combined 4-1BB and ICOS co-stimulation improves anti-tumor efficacy and persistence of dual anti-CD19/CD20 chimeric antigen receptor T cells" [Cytotherapy, Volume 23, Issue 8, 2021, 715-723].
Where this comes from
- Record sourced from PubMed, PMID 39985542.
- Also identified by DOI 10.1016/j.jcyt.2023.09.004.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/about/policies/article-withdrawal.